Biocon gets EIR from USFDA for manufacturing facility in Bengaluru
Posted by
www.biotecnika.org
Biocon on Friday said it has received the establishment inspection
report (EIR) from US health regulator for the post-approval and good
manufacturing practice (GMP) inspection of its small molecules
manufacturing facility in Bengaluru.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-gets-eir-from-usfda-for-manufacturing-facility-in-bengaluru/articleshow/74725567.cms
Subscribe to:
Post Comments (Atom)
Post a Comment